Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

2021.74 (Glytoucan)

Id:3eb16b43-d386-505b-b2a1-7c188333ca3d

Glytoucan:G47809QP

Results found

Linked to

	Label	Description
	2021.74 has glycosequence GLYGEN.GLYCOSEQUENCE:G47809QP-GLYCOSEQ00176031 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2021.74 has glycosequence GLYGEN.GLYCOSEQUENCE:G15478WH-GLYCOSEQ00114439 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2021.74 has glycosequence GLYGEN.GLYCOSEQUENCE:G84026AP-GLYCOSEQ00109418 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2021.74 has glycosequence GLYGEN.GLYCOSEQUENCE:G84026AP-GLYCOSEQ00109419 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2021.74 has glycosequence GLYGEN.GLYCOSEQUENCE:G02776UX-GLYCOSEQ00071503 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2021.74 has motif Lewis b Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2021.74 has glycosequence GLYGEN.GLYCOSEQUENCE:G14589ZB-GLYCOSEQ00031760 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2021.74 has motif Blood group H (type 2) - Lewis y Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2021.74 has glycosequence GLYGEN.GLYCOSEQUENCE:G10287JP-GLYCOSEQ00079428 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2021.74 has glycosequence GLYGEN.GLYCOSEQUENCE:G56525EU-GLYCOSEQ00116528 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2021.74 has glycosequence GLYGEN.GLYCOSEQUENCE:G47809QP-GLYCOSEQ00176031 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2021.74 has glycosequence GLYGEN.GLYCOSEQUENCE:G15478WH-GLYCOSEQ00114439 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2021.74 has glycosequence GLYGEN.GLYCOSEQUENCE:G84026AP-GLYCOSEQ00109418 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2021.74 has glycosequence GLYGEN.GLYCOSEQUENCE:G84026AP-GLYCOSEQ00109419 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2021.74 has glycosequence GLYGEN.GLYCOSEQUENCE:G02776UX-GLYCOSEQ00071503 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2021.74 has motif Lewis b

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2021.74 has glycosequence GLYGEN.GLYCOSEQUENCE:G14589ZB-GLYCOSEQ00031760 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2021.74 has motif Blood group H (type 2) - Lewis y

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2021.74 has glycosequence GLYGEN.GLYCOSEQUENCE:G10287JP-GLYCOSEQ00079428 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2021.74 has glycosequence GLYGEN.GLYCOSEQUENCE:G56525EU-GLYCOSEQ00116528 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.